Trial Profile
Protocol PT 11-29: Randomized, Open-label, Cross-over Pilot Study to Evaluate and Compare Two Omeprazole Containing Products for Relief of Frequent Heartburn
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Omeprazole (Primary) ; Omeprazole/sodium bicarbonate (Primary)
- Indications Heartburn
- Focus Therapeutic Use
- Sponsors Merck & Co
- 24 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 May 2012 New trial record